BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 35735137)

  • 1. Cannabinoid Stability in Postmortem Brain Samples Stored at Different Temperatures.
    Santunione AL; Palazzoli F; Verri P; Vandelli D; Chiapelli F; Silingardi E
    J Anal Toxicol; 2023 Mar; 47(2):121-128. PubMed ID: 35735137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro stability of free and glucuronidated cannabinoids in urine following controlled smoked cannabis.
    Desrosiers NA; Lee D; Scheidweiler KB; Concheiro-Guisan M; Gorelick DA; Huestis MA
    Anal Bioanal Chem; 2014 Jan; 406(3):785-92. PubMed ID: 24292435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro stability of free and glucuronidated cannabinoids in blood and plasma following controlled smoked cannabis.
    Scheidweiler KB; Schwope DM; Karschner EL; Desrosiers NA; Gorelick DA; Huestis MA
    Clin Chem; 2013 Jul; 59(7):1108-17. PubMed ID: 23519966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid Stability in Antemortem and Postmortem Blood.
    Meneses V; Mata D
    J Anal Toxicol; 2020 Mar; 44(2):126-132. PubMed ID: 31711171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An investigation of the stability of free and glucuronidated 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in authentic urine samples.
    Skopp G; Pötsch L
    J Anal Toxicol; 2004; 28(1):35-40. PubMed ID: 14987422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term stability of cannabinoids in oral fluid after controlled cannabis administration.
    Scheidweiler KB; Andersson M; Swortwood MJ; Sempio C; Huestis MA
    Drug Test Anal; 2017 Jan; 9(1):143-147. PubMed ID: 27539096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid distribution in fatally-injured pilots' postmortem fluids and tissues.
    Cliburn KD; Huestis MA; Wagner JR; Kemp PM
    Forensic Sci Int; 2021 Dec; 329():111075. PubMed ID: 34749280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and quantification of cannabinoids in postmortem fluids and tissues by liquid chromatography-tandem mass spectrometry.
    Cliburn KD; Huestis MA; Wagner JR; Kemp PM
    J Chromatogr A; 2021 Aug; 1652():462345. PubMed ID: 34198104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of oral fluid collection device on cannabinoid stability following smoked cannabis.
    Anizan S; Bergamaschi MM; Barnes AJ; Milman G; Desrosiers N; Lee D; Gorelick DA; Huestis MA
    Drug Test Anal; 2015 Feb; 7(2):114-20. PubMed ID: 24995604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmortem redistribution of cannabinoids: Statistical analysis of a novel dataset and meta-analysis.
    Tascon I; Côté C; Garneau B; Desharnais B; Gosselin V; Mireault P
    Forensic Sci Int; 2023 Dec; 353():111873. PubMed ID: 37944415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postmortem redistribution of Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH-THC), and 11-nor-9-carboxy-THC (THCCOOH).
    Holland MG; Schwope DM; Stoppacher R; Gillen SB; Huestis MA
    Forensic Sci Int; 2011 Oct; 212(1-3):247-51. PubMed ID: 21764230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.
    Lee D; Milman G; Barnes AJ; Goodwin RS; Hirvonen J; Huestis MA
    Clin Chem; 2011 Aug; 57(8):1127-36. PubMed ID: 21677094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers?
    Desrosiers NA; Lee D; Concheiro-Guisan M; Scheidweiler KB; Gorelick DA; Huestis MA
    Clin Chem; 2014 Feb; 60(2):361-72. PubMed ID: 24185550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of a recently detected 11-nor-9-carboxy-Δ(9)-tetrahydrocannabinol isomer: Studies on the degradation of 11-nor-9-carboxy-Δ(9)-tetrahydrocannabinol glucuronide.
    Hanisch S; Paulke A; Toennes SW
    J Pharm Biomed Anal; 2016 Sep; 129():294-298. PubMed ID: 27448313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free and Glucuronide Urine Cannabinoids after Controlled Smoked, Vaporized and Oral Cannabis Administration in Frequent and Occasional Cannabis Users.
    Huestis MA; Sempio C; Newmeyer MN; Andersson M; Barnes AJ; Abulseoud OA; Blount BC; Schroeder J; Smith ML
    J Anal Toxicol; 2020 Oct; 44(7):651-660. PubMed ID: 32369162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of postmortem concentrations of Δ
    Hoffman MA; Trochta A; Gary RD; Fitzgerald RL; McIntyre IM
    Forensic Sci Int; 2020 Oct; 315():110414. PubMed ID: 32738674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 11-nor-9-carboxy-Δ
    Hanisch S; Paulke A; Toennes SW
    J Pharm Biomed Anal; 2017 Nov; 146():261-265. PubMed ID: 28892757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid stability in authentic oral fluid after controlled cannabis smoking.
    Lee D; Milman G; Schwope DM; Barnes AJ; Gorelick DA; Huestis MA
    Clin Chem; 2012 Jul; 58(7):1101-9. PubMed ID: 22532594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous quantification of THC-COOH, OH-THC, and further cannabinoids in human hair by gas chromatography-tandem mass spectrometry with electron ionization applying automated sample preparation.
    Kieliba T; Lerch O; Andresen-Streichert H; Rothschild MA; Beike J
    Drug Test Anal; 2019 Feb; 11(2):267-278. PubMed ID: 30144294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The preanalytical stability of emerging cannabinoid analogs (delta-8 THC and its metabolites, delta-10 THC and carboxy-HHC) in urine.
    Pokhai AA; Poklis JL; Williams GR; Wolf CE
    J Anal Toxicol; 2023 Nov; 47(8):726-731. PubMed ID: 37616492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.